CAS 52514-63-3
:Carbidopa impurity E
Description:
Carbidopa impurity E, with the CAS number 52514-63-3, is a chemical compound that is recognized as an impurity associated with the pharmaceutical agent carbidopa, which is primarily used in the treatment of Parkinson's disease. This impurity is typically characterized by its molecular structure, which may include specific functional groups that differentiate it from the parent compound. The presence of impurities like Carbidopa impurity E can affect the purity and efficacy of pharmaceutical formulations, making it essential to monitor and quantify such substances during drug development and manufacturing processes. The compound's stability, solubility, and reactivity are important characteristics that influence its behavior in biological systems and its interactions with other components in a formulation. Regulatory guidelines often dictate acceptable levels of impurities in pharmaceutical products to ensure safety and efficacy for patients. Understanding the characteristics of such impurities is crucial for quality control and compliance in the pharmaceutical industry.
Formula:C11H16N2O4
Synonyms:- (S)-methyl3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoate
- Carbidopa EP Impurity E
- Carbidopa impurity E
- Carbidopa Impurity 5（Carbidopa EP Impurity E）
- methyl (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
Methyl (2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoate (Carbidopa Methyl Ester)
CAS:Controlled ProductFormula:C11H16N2O4Color and Shape:NeatMolecular weight:240.26(S)-Carbidopa Methyl Ester (>90%)
CAS:Controlled Product<p>Applications (S)-Carbidopa Methyl Ester is an S-isomer prodrug of Carbidopa (C175915(M)), which is an inhibitor of aromatic amino acid decarboxylase.<br>References Sletzinger, M., et al.: J. Med. Chem., 6, 101 (1963)<br></p>Formula:C11H16N2O4Purity:>90%Color and Shape:NeatMolecular weight:240.256
